North America Patient Derived Xenograft (PDX) Models Market Business Outlook

Data Bridge Market Research analyses that the patient derived xenograft (PDX) models market which was USD 75167.97 thousand in 2022, is expected to reach USD 269411.99 thousand by 2030, at a CAGR of 17.3% during the forecast period 2023 to 2030.

Market Definition

PDX models are considered an effective tool in biomedical research and preclinical trials because both species have similarities and these models are capable of carrying the tumour's characteristics and studying the tumour and its heterogeneity. They aid in assessing tumour growth rate, life cycle, and growth rate under various conditions. They also aid in distinguishing between adult and paediatric cancer. The use of PDX models in basic cancer research and rug development enables the adoption of new therapies, patient-specific therapies, and personalized medicine.

North America Patient Derived Xenograft (PDX) Models Market Scope

The patient derived xenograft (PDX) models market is segmented on the basis of type, tumour type, application, technique and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.


  • Mice Models
  • Rat Models

Tumor Type

  • GastrointestinalTumor Models
  • Lung Tumor Models
  • Haematological Tumor Models
  • Gynecological Tumor Models
  • Respiratory Tumor Models
  • Urological Tumor Models
  • Others


  • Preclinical Drug Development
  • Precision Medicine
  • Co-Clinical Trials
  • Basic Cancer Research
  • Biomarker Analysis
  • Oncology Research


  • Heterotopic Implantation
  • Orthotropic Implantation

End User

  • Academic and Research Organizations
  • Contract Research Organizations
  • Pharmaceutical and Biotechnological Companies
  • Others

Get The Full Access of Sample Report:-

Patient Derived Xenograft (PDX) Models Market Regional Analysis/Insights

The patient derived xenograft (PDX) models market is analyzed and market size insights and trends are provided by country, type, tumour type, application, technique and end user as referenced above.

The countries covered in the patient derived xenograft (PDX) models market report are U.S., Canada and Mexico in North America.

U.S. is dominating the market due to the strategic initiatives by government and private sector.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Major TOC of The Report

Chapter One:- Introduction

Chapter Two:- Market Definition

Chapter Three:- Market Scope

Get TOC Details:-

Browse Related Reports: -

Global Patient Derived Xenograft (PDX) Models Market

Europe Patient Derived Xenograft (PDX) Models Market

Asia-Pacific Patient Derived Xenograft (PDX) Models Market

About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market


Data Bridge Market Research

Tel: +1-888-387-2818


AK Blog

23 Blog posts